You have 0 free disease views remaining today. Register for more view, it is 100% free →
microcephaly and chorioretinopathy 3
Description
Microcephaly and Chorioretinopathy: A Rare Neuro-Ophthalmological Disease
Microcephaly and chorioretinopathy is a rare neuro-opthalmological disease characterized by severe microcephaly of prenatal onset, which means it affects the development of the brain and eyes before birth. This condition is marked by a diminutive anterior fontanelle (the soft spot on top of the head) and sutural ridging (a sign of premature closure of the skull bones).
Key Features:
- Severe microcephaly, with a head circumference that is 3-4 standard deviations below normal
- Prenatal onset, affecting brain and eye development before birth
- Diminutive anterior fontanelle and sutural ridging
- Variable ocular anomalies, including poor vision and nystagmus (involuntary eye movements)
References:
- [8] A rare neuro-opthalmological disease characterized by severe microcephaly of prenatal onset (with diminutive anterior fontanelle and sutural ridging)
- [6] A disorder characterized by congenital microcephaly and chorioretinal dysplasia associated with poor vision and nystagmus. Variable ocular anomalies include ...
- [3] A syndrome that is characterized by congenital microcephaly and chorioretinal dysplasia associated with poor vision and nystagmus and has material basis in ...
Additional Characteristics
- Severe microcephaly, with a head circumference that is 3-4 standard deviations below normal
- Prenatal onset, affecting brain and eye development before birth
- Diminutive anterior fontanelle and sutural ridging
- Variable ocular anomalies, including poor vision and nystagmus (involuntary eye movements)
- Congenital microcephaly and chorioretinal dysplasia associated with poor vision and nystagmus
- Chorioretinopathy is a rare neuro-opthalmological disease
Signs and Symptoms
Clinical Features of Microcephaly with Chorioretinopathy
Microcephaly with chorioretinopathy, a rare autosomal dominant condition, is characterized by several clinical features. According to various sources [5], the symptoms include:
- Cerebellar hypoplasia: A condition where the cerebellum, responsible for motor coordination and balance, is underdeveloped.
- Cerebral atrophy: Shrinkage of brain tissue, which can lead to cognitive impairment and other neurological problems.
- Global developmental delay: Slowed or impaired development in various aspects, such as physical, cognitive, and emotional growth.
- Intellectual disability: A condition where an individual has significant difficulties with intellectual functioning, affecting their ability to learn, reason, and adapt.
- Macrogyria: An abnormality of the brain's surface, characterized by a thickened or irregular cerebral cortex.
Additionally, individuals with microcephaly with chorioretinopathy may also experience:
- Seizure: A sudden, uncontrolled electrical discharge in the brain that can cause convulsions.
- Simplified gyral pattern: An abnormality of the brain's surface, where the normal folding patterns are disrupted.
These symptoms can vary in severity and presentation among individuals with microcephaly with chorioretinopathy [9].
Additional Symptoms
- Global developmental delay
- Macrogyria
- Intellectual disability
- Cerebral atrophy
- Cerebellar hypoplasia
- Simplified gyral pattern
- seizure
Diagnostic Tests
Diagnostic Tests for Microcephaly and Chorioretinopathy
Microcephaly and chorioretinopathy are rare genetic disorders that can be diagnosed through various diagnostic tests.
- Whole Exome Sequencing: This is a comprehensive genetic test that analyzes the entire exome (the protein-coding part of the genome) to identify mutations in the TUBGCP4 gene, which is associated with microcephaly and chorioretinopathy [3].
- Genetic Testing: Genetic tests can help diagnose microcephaly and chorioretinopathy by identifying mutations in the TUBGCP4 gene. These tests are typically performed on a blood sample or other tissue [1][2][5].
It's worth noting that prenatal testing and carrier testing are also available for families with known gene mutations, which can provide valuable information for parents-to-be [9]. However, if no mutation is identified, fetal MRI may be advised to further assess the condition [9].
References:
[1] by M Bayram-Suverza · 2023 — Genetic tests revealed mutations in the TUBGCP4 gene, leading to a diagnosis of microcephaly and chorioretinopathy.
[2] Feb 22, 2021 — CMV can be tested by urine or salivary PCR within 3 weeks of delivery. Retrospective testing on stored newborn dried blood spots (Guthrie card), ...
[3] Aug 12, 2024 — Management. Genetic variants leading to microcephaly and chorioretinopathy are typically detected by whole exome sequencing, but with increased ...
[5] by M Bayram-Suverza · 2023 — Genetic tests revealed mutations in the TUBGCP4 gene, leading to a diagnosis of microcephaly and chorioretinopathy. As observed in these cases, ...
[9] Prenatal testing and carrier testing are available for families with known gene mutations. When no mutation is identified, fetal MRI could be advised, but ...
Additional Diagnostic Tests
- Genetic Testing
- Whole Exome Sequencing
Treatment
Treatment Options for Microcephaly and Chorioretinopathy
While there are no specific treatments mentioned in the search results, we can infer some general information about the treatment of microcephaly and chorioretinopathy.
- Anticonvulsant therapy: According to search result [10], anticonvulsant therapy should be continued until the morning of surgery and resumed as soon as possible postoperatively. This suggests that anticonvulsants may be used to manage seizures associated with microcephaly and chorioretinopathy.
- No specific treatment mentioned: Unfortunately, there is no mention of any specific treatments for microcephaly and chorioretinopathy in the search results. However, it is essential to consult with a healthcare professional for medical advice and treatment.
Key Points
- Anticonvulsant therapy may be used to manage seizures associated with microcephaly and chorioretinopathy.
- There is no specific treatment mentioned for microcephaly and chorioretinopathy in the search results.
- Consultation with a healthcare professional is essential for medical advice and treatment.
References
[10]
Recommended Medications
- Anticonvulsant therapy
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnoses for Microcephaly and Chorioretinopathy
Microcephaly and chorioretinopathy is a rare genetic disorder that can be challenging to diagnose. Here are some differential diagnoses that should be considered:
- Autosomal Dominant MCLID (Microcephaly, Chorioretinopathy, Lymphedema, and Intellectual Disability): This condition is characterized by variable expression of microcephaly, ocular disorders including chorioretinopathy, congenital lymphedema, and intellectual disability [5].
- Autosomal Recessive Microcephaly-Chorioretinopathy Syndrome: This rare genetic condition is considered an important differential diagnosis for microcephaly and chorioretinopathy. It is characterized by delayed psychomotor development and visual impairment [6].
- Microcephaly with or without Chorioretinopathy, Lymphedema, or Mental Retardation: This autosomal dominant disease is caused by mutations in the KIF11 gene and should be considered as a differential diagnosis for microcephaly and chorioretinopathy [7].
It's essential to note that these differential diagnoses may require further investigation and genetic testing to confirm the diagnosis.
References:
[5] MCLID is a rare autosomal dominant condition characterized by variable expression of microcephaly, ocular disorders including chorioretinopathy, congenital lymphedema, and intellectual disability. [6] Microcephaly and chorioretinopathy is an autosomal recessive developmental disorder characterized by delayed psychomotor development and visual impairment [7] by NÁ Silva · 2024 — Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation is a rare autosomal dominant disease caused by mutations in KIF11.
Additional Differential Diagnoses
- Autosomal Dominant MCLID (Microcephaly, Chorioretinopathy, Lymphedema, and Intellectual Disability)
- Autosomal Recessive Microcephaly-Chorioretinopathy Syndrome
- microcephaly with or without chorioretinopathy, lymphedema, or mental retardation
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_2482
- owl#annotatedSource
- t353215
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0080107
- core#notation
- DOID:0080107
- oboInOwl#hasDbXref
- MIM:616335
- IAO_0000115
- A syndrome that is characterized by congenital microcephaly and chorioretinal dysplasia associated with poor vision and nystagmus and has_material_basis_in compound heterozygous mutation in the TUBGCP4 gene.
- rdf-schema#label
- microcephaly and chorioretinopathy 3
- rdf-schema#subClassOf
- t353821
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000148
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.